Jerry A. Barbee Jr, PharmD, BCPS, CPh
Articles by Jerry A. Barbee Jr, PharmD, BCPS, CPh

Explore Ovarian Cancer Treatments Through Clinical Trials
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP, CGP,Robert W. Maltby,Abby R. Krupnik Guidelines typically recommend debulking surgery, plus systemic chemotherapy for most patients.

Managing Hematologic Cancer Therapies and Reducing COVID-19 Risk
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Chance G. Partlow, PharmD Candidate,Caitlin M. Sacco, PharmD Candidate In this high-risk population, strategies for minimizing viral exposure during a pandemic are being considered with oncology treatment options.

AML Genomic Landscape Plays Key Role in Treatment
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Caitlin M. Sacco Numerous therapeutic options are available for acute myeloid leukemia, but more research is needed to determine how best to use them.

Renal Cell Carcinoma is Treatable and Curable
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Taylor A. VandenBerg Early diagnosis, surgery while cancer is confined to kidney are key, but pharmacological agents are used for Stage IV.

Plethora of Clinical Trials Explore Gastric Cancer Treatments
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Taylor A. VandenBerg, PharmD candidate Pharmacists can play an integral role in collaborating with physicians to manage patient therapy.

CAR-NK Cell Immunotherapy Shows Promise
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Caitlyn Tompkins Patients with relapsed or refractory lymphomas may benefit from CAR-NK cell immunotherapy and Have fewer adverse events.

Early Screening Is Key in Colorectal Cancer
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCGP, BCACP, BCIDP,Hayato DeLellis, PharmD candidate,Chelsea Phillips, PharmD candidate New treatments with biological agents and vaccines are creating a pathway for patients with metastatic CRC.

Prevention is Key for Non-Small Cell Lung Cancer
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCG, BCIDP,Carys Davies, PharmD Candidate Despite numerous treatment advances, early detection, public education, and smoking cessation are the best bets.

New Skin Cancer Treatments Show Promise
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCGP, BCACP, BCIDP,Carys Davies, PharmD Candidate Advances in research and immunotherapy have led to breakthroughs regarding biologics targeting melanoma.

Vaccines Play a Role in Cancer Treatment
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Sam Sowell, PharmD Candidate There Is Room for Improvement in Treating Malignancies Caused by Infectious Agents, Especially Considering the Cost Differential

What Are the Newest Breast Cancer Treatment Options?
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Matthew Bailey, PharmD Candidate,William Ray Stevens, PharmD Candidate Cyclin-Dependent Kinase 4/6 Inhibitors, Margetuximab, Trastuzumab Deruxtecan, and Tyrosine Kinase Inhibitors Have Shown Promising Results

SBRT Improves Options for Prostate Cancer
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Meagan Balding, PharmD Candidate,D. Garrett Smith, PharmD candidate For some patients, stereotactic body radiation therapy may provide an enhanced quality of life, better efficacy, and reduced adverse effects.

Cancer Pain Treatment Remains a Challenge
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Matthew Bailey, PharmD Candidate,Meagan Balding, PharmD Candidate,Amanda Boyer, PharmD Candidate Some patients are hesitant to use this class of drugs because of the stigma of potential addiction.

Leukemia: Causes, Symptoms, and Treatments
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP, BCGP,Christen Ferguson, PharmD candidate,Jasmin Tawfic, PharmD candidate Leukemia is a type of cancer that affects blood cell formation and the lymphatic system. It can be classified by cell type, lymphoid or myeloid, and the rate of progression, acute or chronic.

Relevant Studies for Non-Hodgkin's Lymphoma
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP, BCGP,Jasmin Tawfic, PharmD candidate Several studies represent some of the important clinical trials in the treatment of Non-Hodgkin's Lymphoma.

Renal Carcinoma: Causes, Symptoms, and Treatments
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP, BCGP,Matthew Bailey, PharmD Candidate,Amanda Boyer, PharmD Candidate The number of individuals diagnosed with cancer steadily increases each year.

Yes, things have and are changing, but my vision to aid the patient with their health care needs has not changed.

I went to work for an independent pharmacist, some 43 years ago, for the chance to learn something about the profession of pharmacy. The profession has changed so much from the original journey I envisioned.

April is Parkinson's Disease awareness month, spotlighting this disorder of the central nervous system that affects movement.

March is multiple sclerosis awareness month.

March is MS awareness month, spotlighting this chronic, progressive disease that is growing in prevalence.

You have been working towards Match Day for a while, but once it is over where do you go next?

Breast Cancer: the Clinician's Involvement
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP, BCGP,Joseph Adelufosi, PharmD Candidate,Aericka O'Neal-Scott, PharmD Candidate For many women, the fear of breast cancer is always present.

Cancer Screening: Seeing the Future?
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP, BCGP,Matthew Bailey, PharmD Candidate,Amanda Boyer, PharmD Candidate Cancer is the second-leading cause of death in the United States.

Here are some tips to optimize your interview day and show prospective residency programs your potential.

'What do I need to bring to your rotation?' This question sounds so tangible, but it is mostly the intangible things that make the difference.

Lung Cancers: Facts, Causes, and Types
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP, BCGP,Catherine M. Kew, PharmD Candidate,Emily V. Olivier, PharmD Candidate In 2017, lung cancer is projected to be the second most prevalent type of cancer in the United States, with about 222,500 new cases and is estimated to still be the leading cause of cancer-related death, with 155,870 deaths.